FSA
ARIA

Franklin Street Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Franklin Street Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33,600
Closed -$418K – 184
2016
Q4 		$418K Hold
33,600
– – 0.07% 127
2016
Q3 		$460K Sell
33,600
-11,500
-25% -$115K 0.08% 132
2016
Q2 		$333K Sell
45,100
-8,500
-16% -$63.8K 0.06% 150
2016
Q1 		$343K Sell
53,600
-15,000
-22% -$84.1K 0.07% 163
2015
Q4 		$429K Sell
68,600
-10,650
-13% -$69.9K 0.08% 151
2015
Q3 		$463K Sell
79,250
-2,150
-3% -$16.6K 0.09% 143
2015
Q2 		$673K Hold
81,400
– – 0.12% 134
2015
Q1 		$671K Hold
81,400
– – 0.12% 128
2014
Q4 		$559K Sell
81,400
-43,000
-35% -$269K 0.11% 128
2014
Q3 		$672K Buy
124,400
+11,100
+10% +$64.8K 0.13% 141
2014
Q2 		$722K Buy
113,300
+12,300
+12% +$84.6K 0.14% 142
2014
Q1 		$814K Buy
101,000
+32,400
+47% +$252K 0.16% 137
2013
Q4 		$468K Sell
68,600
-96
-0.1% -$518 0.09% 169
2013
Q3 		$1.26M Hold
68,696
– – 0.28% 86
2013
Q2 		$1.2M Buy
+68,696
New +$1.22M 0.3% 91

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Franklin Street Advisors's ARIA Position: Q1 2017 in Review

Franklin Street Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 33,600 shares — an estimated $418K sold.

Franklin Street Advisors first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $1.26M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Franklin Street Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Franklin Street Advisors sold 33,600 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $418K.
  • Franklin Street Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Franklin Street Advisors's Ariad Pharmaceuticals Inc position peaked at $1.26M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Franklin Street Advisors's 13F filing for Q1 2017, filed 4 Apr 2017.